01:51 PM EDT, 05/15/2026 (MT Newswires) -- Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index falling 0.9% and the State Street Healthcare Select Sector SPDR ETF (XLV) shedding 0.8%.

The iShares Biotechnology ETF (IBB) dropped 2.5%.

In corporate news, Aardvark Therapeutics ( AARD ) shares fell 31% after the firm said the US Food and Drug Administration placed a full clinical hold on its investigational new drug application for ARD-101. Morgan Stanley downgraded the stock to underweight from equalweight, and BTIG to neutral from buy.

DexCom ( DXCM ) said Friday it has set new long-term financial goals, including organic revenue growth of more than 10% a year through 2030. Its shares climbed past 6%.

ARS Pharmaceuticals ( SPRY ) shares fell nearly 5% after it posted a wider Q1 net loss.

Alumis ( ALMS ) stock was down more than 5% after it reported that its Q1 revenue dropped to $1.7 million from $17.4 million a year earlier.